We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$390M
AUM Growth
$0
Cap. Flow
-$658K
Cap. Flow %
-0.17%
Top 10 Hldgs %
36.69%
Holding
181
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$257K
2
NTES icon
NetEase
NTES
+$215K
3
NEE icon
NextEra Energy
NEE
+$186K

Sector Composition

Rank Sector Weight
1 Healthcare 24.4%
2 Technology 24.34%
3 Consumer Discretionary 11.23%
4 Communication Services 8.9%
5 Consumer Staples 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$153B
$4.75M 1.22%
129,508
-6,993
-5% -$257K
AMT icon
27
American Tower
AMT
$80.4B
$4.37M 1.12%
18,082
– –
INTC icon
28
Intel
INTC
$513B
$3.92M 1.01%
75,715
– –
LLY icon
29
Eli Lilly
LLY
$1.06T
$3.61M 0.92%
24,362
– –
PEP icon
30
PepsiCo
PEP
$190B
$3.47M 0.89%
25,029
– –
BMY icon
31
Bristol-Myers Squibb
BMY
$132B
$3.38M 0.87%
56,064
– –
QRVO icon
32
Qorvo
QRVO
$8.74B
$3.31M 0.85%
25,635
– –
SO icon
33
Southern Company
SO
$107B
$3.01M 0.77%
55,454
– –
CSCO icon
34
Cisco
CSCO
$479B
$2.95M 0.76%
74,886
– –
ED icon
35
Consolidated Edison
ED
$39.9B
$2.88M 0.74%
37,085
– –
BRK.B icon
36
Berkshire Hathaway Class B
BRK.B
$1.13T
$2.64M 0.68%
12,394
– –
DXCM icon
37
DexCom
DXCM
$32B
$2.51M 0.64%
24,336
– –
D icon
38
Dominion Energy
D
$59.3B
$2.46M 0.63%
31,199
– –
TFC icon
39
Truist Financial
TFC
$64B
$2.41M 0.62%
63,356
– –
MRK icon
40
Merck
MRK
$318B
$2.32M 0.6%
29,337
– –
VUG icon
41
Vanguard Morningstar Growth ETF
VUG
$230B
$2.14M 0.55%
56,472
– –
XOM icon
42
ExxonMobil
XOM
$634B
$1.93M 0.49%
56,158
– –
T icon
43
AT&T
T
$163B
$1.92M 0.49%
89,063
– –
RGCO icon
44
RGC Resources
RGCO
$228M
$1.77M 0.46%
75,685
– –
HZNP
45
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.77M 0.45%
22,775
– –
DUK icon
46
Duke Energy
DUK
$97.3B
$1.66M 0.43%
18,791
– –
VWO icon
47
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$1.65M 0.42%
38,101
– –
VNQ icon
48
Vanguard Real Estate ETF
VNQ
$39.1B
$1.53M 0.39%
19,425
– –
JPC icon
49
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$1.53M 0.39%
179,700
– –
EFX icon
50
Equifax
EFX
$21.4B
$1.51M 0.39%
9,623
– –
1
2
3 4 5

Similar funds

BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

Dixon Hubard Feinour & Brown's Q4 2020 Portfolio in Review

As of Q4 2020, Dixon Hubard Feinour & Brown held 181 positions worth $390M, unchanged from the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 0%. Dixon Hubard Feinour & Brown opened no new positions and made no exits, leaving the 181-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, unchanged from a quarter earlier, followed by Technology and Consumer Discretionary.

  • Dixon Hubard Feinour & Brown's biggest Q4 2020 reduction was Pfizer, cutting an estimated $257K.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 37% of its $390M portfolio in Q4 2020.
  • Dixon Hubard Feinour & Brown opened 0 new positions and closed 0 in Q4 2020.
  • Dixon Hubard Feinour & Brown's portfolio value was unchanged quarter-over-quarter at $390M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2020, filed 12 Feb 2021.